Literature DB >> 7691756

Compartmentalization of defined epitopes expressed in Escherichia coli has only a minor influence on efficiency of phagocytic processing for presentation by class I and class II major histocompatibility complex molecules to T cells.

M J Wick1, J D Pfeifer, K A Findlay, C V Harding, S J Normark.   

Abstract

The effect of abundance and compartmentalization of antigenic epitopes expressed in Escherichia coli on phagocytic processing was studied by expressing fusion proteins containing the epitope from positions 52 to 61 of hen egg white lysozyme [HEL(52-61)], which binds the I-Ak murine major histocompatibility complex class II (MHC-II) molecule or the epitope from positions 257 to 264 of chicken egg ovalbumin [OVA(257-264]), which binds the Kb murine MHC-I molecule. Epitopes expressed as fusion proteins in the outer membrane protein LamB allowed exposure of the epitopes either at the bacterial surface, in the periplasmic space, or in the cytoplasm. Regardless of epitope compartmentalization within the bacterium, MHC-II-restricted or MHC-I-restricted presentation to T hybridoma cells occurred after macrophages phagocytosed bacteria producing the HEL(52-61) epitope or the OVA(257-264) epitope, respectively. Increased epitope abundance within a given microbial compartment resulted in increased processing and presentation to epitope-specific T hybridoma cells. Minor differences in the efficiency of epitope processing between the constructs was observed, and the HEL or OVA epitope exposed in the periplasmic space was processed most efficiently compared with the surface- or cytoplasm-localized epitopes. These differences could be overcome by increasing the amount of epitope per bacterium as little as two to five times. The minor differences in processing efficiency may be due to differing protein contexts of the epitope as well as differing epitope compartmentalizations within the bacteria. Thus, production of abundant epitope is the important parameter influencing processing of epitopes expressed in E. coli to induce T-cell responses rather than targeting of an epitope to a specific bacterial compartment.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7691756      PMCID: PMC281243          DOI: 10.1128/iai.61.11.4848-4856.1993

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  43 in total

1.  The preferential synthesis of beta-galactosidase in Escherichia coli.

Authors:  H V RICKENBERG; G LESTER
Journal:  J Gen Microbiol       Date:  1955-10

2.  DNA sequence for a low-level promoter of the lac repressor gene and an 'up' promoter mutation.

Authors:  M P Calos
Journal:  Nature       Date:  1978-08-24       Impact factor: 49.962

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Sequences of the malE gene and of its product, the maltose-binding protein of Escherichia coli K12.

Authors:  P Duplay; H Bedouelle; A Fowler; I Zabin; W Saurin; M Hofnung
Journal:  J Biol Chem       Date:  1984-08-25       Impact factor: 5.157

5.  Intragenic suppressor mutations that restore export of maltose binding protein with a truncated signal peptide.

Authors:  V A Bankaitis; B A Rasmussen; P J Bassford
Journal:  Cell       Date:  1984-05       Impact factor: 41.582

6.  Sequence analysis of mutations that prevent export of lambda receptor, an Escherichia coli outer membrane protein.

Authors:  S D Emr; J Hedgpeth; J M Clément; T J Silhavy; M Hofnung
Journal:  Nature       Date:  1980-05-08       Impact factor: 49.962

7.  Exons encode functional and structural units of chicken lysozyme.

Authors:  A Jung; A E Sippel; M Grez; G Schütz
Journal:  Proc Natl Acad Sci U S A       Date:  1980-10       Impact factor: 11.205

8.  Sequence of chicken ovalbumin mRNA.

Authors:  L McReynolds; B W O'Malley; A D Nisbet; J E Fothergill; D Givol; S Fields; M Robertson; G G Brownlee
Journal:  Nature       Date:  1978-06-29       Impact factor: 49.962

9.  In vivo properties of a cloned K88 adherence antigen determinant.

Authors:  G Dougan; R Sellwood; D Maskell; K Sweeney; F Y Liew; J Beesley; C Hormaeche
Journal:  Infect Immun       Date:  1986-04       Impact factor: 3.441

10.  Priming immunization against cholera toxin and E. coli heat-labile toxin by a cholera toxin short peptide-beta-galactosidase hybrid synthesized in E. coli.

Authors:  C O Jacob; M Leitner; A Zamir; D Salomon; R Arnon
Journal:  EMBO J       Date:  1985-12-01       Impact factor: 11.598

View more
  5 in total

Review 1.  Diversity in MHC class II antigen presentation.

Authors:  John H Robinson; Alexei A Delvig
Journal:  Immunology       Date:  2002-03       Impact factor: 7.397

Review 2.  Class I MHC presentation of exogenous antigens.

Authors:  C V Harding
Journal:  J Clin Immunol       Date:  1996-03       Impact factor: 8.317

3.  Parameters that influence the efficiency of processing antigenic epitopes expressed in Salmonella typhimurium.

Authors:  M J Wick; C V Harding; S J Normark; J D Pfeifer
Journal:  Infect Immun       Date:  1994-10       Impact factor: 3.441

4.  Systems biology approach predicts antibody signature associated with Brucella melitensis infection in humans.

Authors:  Li Liang; Xiaolin Tan; Silvia Juarez; Homarh Villaverde; Jozelyn Pablo; Rie Nakajima-Sasaki; Eduardo Gotuzzo; Mayuko Saito; Gary Hermanson; Douglas Molina; Scott Felgner; W John W Morrow; Xiaowu Liang; Robert H Gilman; D Huw Davies; Renée M Tsolis; Joseph M Vinetz; Philip L Felgner
Journal:  J Proteome Res       Date:  2011-09-08       Impact factor: 4.466

Review 5.  Transgenic Leishmania and the immune response to infection.

Authors:  L Beattie; K J Evans; P M Kaye; D F Smith
Journal:  Parasite Immunol       Date:  2008-02-04       Impact factor: 2.280

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.